Hikma Pharmaceuticals Regulatory News (HIK)

14 Sep 2007 14:58

Hikma Pharmaceuticals Plc14 September 2007 Hikma Pharmaceuticals PLC14 September 2007 NOTIFICATION OF TRANSACTION OF DIRECTOR/PERSONS DISCHARGING MANAGERIALRESPONSIBILITY AND CONNECTED PERSONSThis form is intended for use by an issuer to make a RIS notification required by DTR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to theshares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer HIKMA PHARMACEUTICALS PLC .................................... 2. State whether the notification relates to (i) a transaction notified inaccordance with DTR 3.1.4R(1)(a); or (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) a disclosure made in accordance with section 793 of the Companies Act 2006. (i) .................................... 3. Name of person discharging managerial responsibilities/director MR GABRIEL KALISSE .................................... 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify the connected person MS MONA RAFIQ SHUHAIBAR (SPOUSE) .................................... 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest 4 ABOVE .................................... 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY SHARES OF 10 PENCE EACH .................................... 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them ML NOMINEES LIMITED .................................... 8 State the nature of the transaction SALE OF SHARES .................................... 9. Number of shares, debentures or financial instruments relating to sharesacquired N/A .................................... 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A .................................... 11. Number of shares, debentures or financial instruments relating to shares disposed 61,920 .................................... 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 0.0366% .................................... 13. Price per share or value of transaction 398.0 PENCE PER SHARE .................................... 14. Date and place of transaction 12 SEPTEMBER 2007, BAHRAIN .................................... 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account when calculating percentage) NIL .................................... 16. Date issuer informed of transaction 14 SEPTEMBER 2007 .................................... If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant .................................... 18. Period during which or date on which it can be exercised .................................... 19. Total amount paid (if any) for grant of the option .................................... 20. Description of shares or debentures involved (class and number) .................................... 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise .................................... 22. Total number of shares or debentures over which options held followingnotification .................................... 23. Any additional information N/A .................................... 24. Name of contact and telephone number for queries HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760 .................................... Name and signature of duly authorised officer of issuer responsible for making notification HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760 .................................... Date of notification 14 SEPTEMBER 2007 .................................... END This information is provided by RNS The company news service from the London Stock Exchange